News

Video

Updates in First-Line Systemic Therapy for Advanced HCC: The HIMALAYA Study

Dr Manish Shah reviews data from the HIMALAYA study on front-line systemic therapy in advanced HCC with tremelimumab plus durvalumab.

Video Player is loading.
Current Time 0:00
Duration 10:54
Loaded: 0%
Stream Type LIVE
Remaining Time 10:54
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
Related Content